ZA99453B - Adhesion receptor blocker for ÓV-integrins. - Google Patents
Adhesion receptor blocker for ÓV-integrins.Info
- Publication number
- ZA99453B ZA99453B ZA9900453A ZA99453A ZA99453B ZA 99453 B ZA99453 B ZA 99453B ZA 9900453 A ZA9900453 A ZA 9900453A ZA 99453 A ZA99453 A ZA 99453A ZA 99453 B ZA99453 B ZA 99453B
- Authority
- ZA
- South Africa
- Prior art keywords
- integrins
- receptor blocker
- adhesion receptor
- adhesion
- blocker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98101108 | 1998-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA99453B true ZA99453B (en) | 1999-07-21 |
Family
ID=8231295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9900453A ZA99453B (en) | 1998-01-23 | 1999-01-21 | Adhesion receptor blocker for ÓV-integrins. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1049718B1 (xx) |
JP (1) | JP2002501086A (xx) |
KR (1) | KR20010034327A (xx) |
CN (1) | CN1168741C (xx) |
AR (1) | AR014464A1 (xx) |
AT (1) | ATE322508T1 (xx) |
AU (1) | AU2716399A (xx) |
BR (1) | BR9907218A (xx) |
CA (1) | CA2319160A1 (xx) |
DE (1) | DE69930723T2 (xx) |
HU (1) | HUP0101151A3 (xx) |
ID (1) | ID27810A (xx) |
NO (1) | NO20003767D0 (xx) |
PL (1) | PL341569A1 (xx) |
SK (1) | SK10772000A3 (xx) |
WO (1) | WO1999037683A1 (xx) |
ZA (1) | ZA99453B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2270147T4 (da) | 1999-04-09 | 2020-08-31 | Kyowa Kirin Co Ltd | Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle |
US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
CZ20033119A3 (cs) | 2001-04-24 | 2005-01-12 | Merck Patent Gmbh | Kombinovaná terapie za použití antiangiogenových činidel a TNF alfa |
CA2453403C (en) | 2001-07-09 | 2013-10-08 | Elan Pharmaceuticals, Inc. | Methods of inhibiting amyloid toxicity |
US7829087B2 (en) | 2001-07-09 | 2010-11-09 | Elan Pharmaceuticals, Inc. | Methods of treating cognitive impairment |
EP2287198A3 (en) * | 2002-03-13 | 2011-05-25 | Biogen Idec MA Inc. | Anti-alpha V beta 6 antibodies |
CN104072614B (zh) | 2005-07-08 | 2017-04-26 | 生物基因Ma公司 | 抗-αvβ6 抗体及其用途 |
EA016817B1 (ru) | 2006-01-18 | 2012-07-30 | Мерк Патент Гмбх | Специфическая терапия, использующая интегриновые лиганды для лечения рака |
UA100969C2 (uk) | 2006-03-21 | 2013-02-25 | Дженентек, Інк. | Антитіло, яке специфічно зв'язує людський альфа5бета1 (alpha5beta1) |
AU2007272995B2 (en) | 2006-07-10 | 2013-02-07 | Biogen Idec Ma Inc. | Compositions and methods for inhibiting growth of smad4-deficient cancers |
AU2007348941B2 (en) | 2006-08-03 | 2011-08-04 | Medimmune Limited | Antibodies directed to alphaVbeta6 and uses thereof |
KR20090108713A (ko) | 2007-01-18 | 2009-10-16 | 메르크 파텐트 게엠베하 | 인테그린 리간드를 사용하는 암치료용 특이적 요법 및 의약 |
US7973138B2 (en) | 2007-09-26 | 2011-07-05 | Genentech, Inc. | Antibodies |
ES2457822T3 (es) | 2007-11-08 | 2014-04-29 | The General Hospital Corporation | Procedimientos y composiciones de tratamiento de enfermedades proteinúricas |
MY173526A (en) | 2009-03-25 | 2020-01-31 | Genentech Inc | Novel anti-?5?1 antibodies and uses thereof |
KR20120104491A (ko) | 2009-05-25 | 2012-09-21 | 메르크 파텐트 게엠베하 | 암 치료를 위한 실렌기티드의 연속 투여 |
BR112012020790B1 (pt) * | 2010-02-18 | 2021-09-28 | The Regents Of The University Of California | Anticorpo isolado anti-integrina alfavbeta8 e composição farmacêutica |
WO2014144466A1 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
WO2014143739A2 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI0719859T1 (en) * | 1994-12-20 | 2003-12-31 | Merck Patent Gmbh | Anti-alpha V-integrin monoclonal antibody |
-
1999
- 1999-01-11 CN CNB998022829A patent/CN1168741C/zh not_active Expired - Fee Related
- 1999-01-11 HU HU0101151A patent/HUP0101151A3/hu unknown
- 1999-01-11 AU AU27163/99A patent/AU2716399A/en not_active Abandoned
- 1999-01-11 ID IDW20001566A patent/ID27810A/id unknown
- 1999-01-11 SK SK1077-2000A patent/SK10772000A3/sk unknown
- 1999-01-11 KR KR1020007008052A patent/KR20010034327A/ko not_active Application Discontinuation
- 1999-01-11 AT AT99907361T patent/ATE322508T1/de not_active IP Right Cessation
- 1999-01-11 EP EP99907361A patent/EP1049718B1/en not_active Expired - Lifetime
- 1999-01-11 DE DE69930723T patent/DE69930723T2/de not_active Expired - Lifetime
- 1999-01-11 PL PL99341569A patent/PL341569A1/xx unknown
- 1999-01-11 WO PCT/EP1999/000101 patent/WO1999037683A1/en active Search and Examination
- 1999-01-11 JP JP2000528603A patent/JP2002501086A/ja active Pending
- 1999-01-11 CA CA002319160A patent/CA2319160A1/en not_active Abandoned
- 1999-01-11 BR BR9907218-1A patent/BR9907218A/pt not_active IP Right Cessation
- 1999-01-21 ZA ZA9900453A patent/ZA99453B/xx unknown
- 1999-01-22 AR ARP990100258A patent/AR014464A1/es not_active Application Discontinuation
-
2000
- 2000-07-21 NO NO20003767A patent/NO20003767D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0101151A2 (hu) | 2001-08-28 |
CN1288469A (zh) | 2001-03-21 |
CN1168741C (zh) | 2004-09-29 |
EP1049718B1 (en) | 2006-04-05 |
JP2002501086A (ja) | 2002-01-15 |
BR9907218A (pt) | 2000-10-24 |
SK10772000A3 (sk) | 2001-01-18 |
KR20010034327A (ko) | 2001-04-25 |
EP1049718A1 (en) | 2000-11-08 |
DE69930723T2 (de) | 2006-11-16 |
PL341569A1 (en) | 2001-04-23 |
HUP0101151A3 (en) | 2004-06-28 |
ID27810A (id) | 2001-04-26 |
NO20003767L (no) | 2000-07-21 |
WO1999037683A1 (en) | 1999-07-29 |
CA2319160A1 (en) | 1999-07-29 |
ATE322508T1 (de) | 2006-04-15 |
DE69930723D1 (de) | 2006-05-18 |
AU2716399A (en) | 1999-08-09 |
AR014464A1 (es) | 2001-02-28 |
NO20003767D0 (no) | 2000-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA974234B (en) | Adhesion receptor antagonists. | |
AU5203999A (en) | Beta3-adrenergic receptor agonists | |
AU3615599A (en) | Melanocortin receptor ligands | |
HK1035671A1 (en) | Adenosine a3 receptor modulators. | |
ZA985678B (en) | 1-amino-alkylcyclohexane NMDA receptor antagonists. | |
ZA99453B (en) | Adhesion receptor blocker for ÓV-integrins. | |
ZA200107411B (en) | Melanocortin receptor ligands. | |
AU4698299A (en) | 5-HT7 receptor antagonists | |
ZA961946B (en) | Receptor activation by gas6. | |
AU7132898A (en) | Edg-1-like receptor | |
IL146151A0 (en) | Human-g-protein receptor | |
AU3468599A (en) | Gaba b receptor | |
EP1084142A4 (en) | GPR35A RECEIVER | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
AU1863200A (en) | Service riser | |
AU2234199A (en) | Il-8 receptor antagonists | |
GB9819420D0 (en) | Novel receptor | |
AU3543599A (en) | Receptors | |
ZA995029B (en) | Estrogen agonists/antagonists. | |
AU5478599A (en) | C3a receptor ligands | |
EP1131335A4 (en) | 7TM RECEPTOR HLWAR77 | |
ZA981338B (en) | Neurturin receptor. | |
AU6826498A (en) | Endotholin receptor antagonists | |
EP1083909A4 (en) | hCEPR RECEPTOR | |
EP1054966A4 (en) | AMMAID, A G PROTEIN-COUPLED RECEPTOR |